Nothing Special   »   [go: up one dir, main page]

CN1869652A - Investigating agent and method of serum sodium ion enzyme method - Google Patents

Investigating agent and method of serum sodium ion enzyme method Download PDF

Info

Publication number
CN1869652A
CN1869652A CN 200610028451 CN200610028451A CN1869652A CN 1869652 A CN1869652 A CN 1869652A CN 200610028451 CN200610028451 CN 200610028451 CN 200610028451 A CN200610028451 A CN 200610028451A CN 1869652 A CN1869652 A CN 1869652A
Authority
CN
China
Prior art keywords
reagent
ether
concentration
mmol
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200610028451
Other languages
Chinese (zh)
Other versions
CN100554939C (en
Inventor
朱绍荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RONGSHENG BIOLOGICAL TECHNOLOGY Co Ltd SHANGHAI
Original Assignee
RONGSHENG BIOLOGICAL TECHNOLOGY Co Ltd SHANGHAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RONGSHENG BIOLOGICAL TECHNOLOGY Co Ltd SHANGHAI filed Critical RONGSHENG BIOLOGICAL TECHNOLOGY Co Ltd SHANGHAI
Priority to CNB2006100284511A priority Critical patent/CN100554939C/en
Publication of CN1869652A publication Critical patent/CN1869652A/en
Application granted granted Critical
Publication of CN100554939C publication Critical patent/CN100554939C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses an in-serum sodium ion enzyme method determining reagent and method, finding a relatively good concentration by applying different reagent proportions on complexing ability of crown ether which has characters of cavity ether and sodium ions, and it is the same as the cavity ether in the aspects of sensitivity, accuracy, and precision. And the invention has determining effect similar to the determining effect obtained by the method adopting cavity ether, but the invention is simple and convenient and largely reduces cost.

Description

Serum sodium ion by enzymatic method is measured reagent and method
Technical field
The invention belongs to the clinical biochemical analytical approach, be used for the mensuration of serum sodion.
Background technology
In biochemical clinical trial, it is analysis project conventional in the hospital that serum sodium ion is measured.The normal value of sodium is 136-145mmol/L, and common clinically electrolyte disturbance is a hyponatremia.
The analytical approach of sodion is a flame photometry the earliest.The principle of this method is that some sodium atom to be measured is excited by adding thermostimulation, sends the light with characteristic wavelength when getting back to ground state.The characteristic wavelength that produces by the sodium atom to be measured that is excited in the flame, the intensity of radiation energy directly is directly proportional with the quantity of the sodium atom to be measured that is excited in the flame, and the sodium atom quantity to be measured that is excited directly is directly proportional with the concentration of sodium atom to be determined in the sample.The device that this method needs is complicated and expensive, and will use inflammable gas.
The sodion method for measuring of generally using in the hospital is an ion selective electrode method at present.Ideal situation is that each electrode all has single ion selectivity, and electrode is only responded to a kind of ion.Actual conditions but are not that all ion-selective electrodes all have interfering ion like this.Moreover although can proofread and correct ion specificity electrode, usually specificity still is not absolute, so the result who records with the electrode method neither be very accurate.And cost of determination is also than higher, and especially auxiliary material and instrument are relatively more expensive.
The enzymatical detection method that had occurred serum sodium ion in recent years again.The theoretical foundation of this assay method is the effect that many ions all have kinase.The measuring principle of sodion is the enzyme kinetics reaction detection sodium by sodium dependence beta galactosidase catalytic substrate O-nitro pyranoside, and its product O-nitrophenols rises proportional with na concn at the light absorption value of 405nm.Because Na ion concentration is too high in the serum, is unsuitable for direct mensuration, needs to add ionophore complexing part sodion, thereby sodion is adjusted to a suitable concentration.Enzyme is the most responsive to the subtle change of sodion in this concentration range, so just can obtain measurement result more accurately.
Enzymatic assays is not only accurate, and convenient, can reinstate fully-automatic analyzer with other conventional sense project one and detect, and has broken away from the instrument of original electrode method, has also reduced the detection cost simultaneously.Electrode method originally not only will be bought instrument in addition, but also to often change electrode, and the consumption of electrolytic solution is also than comparatively fast, and these reasons make sodion cost in the determination of electrode serum than higher, and adopt enzymatic assays just not have these problems, so cost of determination reduces a lot.
Summary of the invention
The purpose of this invention is to provide a kind of reagent with sodion in the enzymatic assays serum.
Another object of the present invention provides the assay method of this reagent.
It is composed as follows that serum sodium ion by enzymatic method provided by the invention is measured reagent:
R 1Reagent Concentration (MMOL/L)
TRIS buffer pH8.7 (37 ℃) 500mmol/L
3-mercaptoethanol 5mmol/L
MgSO 4 6mmol/L
LiCl 50-100mmol/L
Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium 0.5-5mmol/L
15-is preced with-5 ethers 10-25mmol/L
β-galactosidase (beta galactosidase) 1000-4000U/L
R 2Reagent Concentration (MMOL/L)
O-nitro-β-D-pyranoside 10-20mmol/L
Reagent of the present invention is made up of dilution and dried frozen aquatic products.Because the time that some component is preserved in aqueous solution is very short, so want freeze-drying to preserve.Amount ratio when R1 and R2 test is: 2.5: 1, so the amount of preparation ratio is 2.5: 1.Process for preparation is as follows:
R 1
(1) dilution: (1000ml)
Tris-Hcl buffr pH 8.7 (25 ℃) 500mmol/L 1000ml accurately adds following material successively:
MgSO 4
LiCl
Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium
15-is preced with-5 ethers
(2) dried frozen aquatic products: (100ml, 10 times of concentrates)
Tris-Hcl buffer pH8.7 (25 ℃) 500mmol/L 100ml accurately adds following material successively:
3-mercaptoethanol
β-galactosidase
Sucrose 18 grams (forming agent)
R 2
(1) dilution (400ml)
Tris buffer pH8.7(25℃)10.0mmol/L 400ml
(2) dried frozen aquatic products (100ml, 4 times of concentrates)
The new H that steams 2O 100ml accurately adds following material successively:
O-nitro-β-D-pyranoside
Sucrose 15 grams (forming agent)
Except that ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium, can buy.Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium be spent glycol (alpha-amido ethyl) ether tetraacethyl (be called for short: EGTA) and lithium hydroxide (LiOH) prepare.Method is as follows: take by weighing 1.902gEGTA and be dissolved in the 5ml deionized water, the LiOH solution that adds 4mol/L more all dissolves to EGTA, is diluted to 50ml with deionized water again.(pH should be 8.7,25 ℃).Take according to the consumption in the prescription during preparation finished product reagent.
The present invention utilizes crown ether to have the characteristics of cave ether and the ability of sodion complexing, adopts the proportioning of different reagent to seek out the above serum sodium ion by enzymatic method that is used for and measures reagent.
Key of the present invention has been to use a kind of novel ionophore, this carrier low price, and it belongs to the crown ether-like material.What be that they use with the method difference of bibliographical information is a kind of cave ethers carrier Kryptofix-2.2.1 (being called for short K221), and its chemical molecular formula is C 16H 32N 2O 5, and cave ether is very expensive, about 4000 yuans of 1ml.The crown ether-like carrier that we use is very cheap.Screening through prescription has obtained reasonable measurement result.The chemical formula of this material is as follows: 15-crown-5 is called: 15-is preced with-5 ethers, molecular formula: C 10H 20O 5Bibliographical information (Lin Zili, the application progress of crown compound colorimetric estimation potassium sodium are arranged.) cave ether and crown ether be as follows to the complexing power of sodion:
With Na +The complexing stability constant Complexing power is (cave ether/crown ether) relatively
15-is preced with-5 ethers 1.2×10 6 3×10 4
Cave ether K221 3.6×10 10
Owing to the hole is arranged in their macrocyclic structure, in addition Nei Bu oxygen atom have share electron pair can with complexing of metal ion, so according to the size in hole, the metallic ion of alternative complexing different-diameter.Though the ability of crown ether-like material complexing sodion is nothing like the cave ether material, we have screened a reasonable concentration through a large amount of experiments, are obtaining aspect sensitivity, accuracy, the precision and are using the identical effect of cave ether.
The typical concentration scope of the main agents that serum sodium ion is measured is as follows:
R 1Reagent Concentration (MMOL/L)
TRIS buffer pH8.7 (37 ℃) 500mmol/L
3-mercaptoethanol 5mmol/L
MgSO 4 6mmol/L
LiCl 50-100mmol/L
Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium 0.5-5mmol/L
15-is preced with-5 ethers 10-25mmol/L
β-galactosidase (beta galactosidase) 1000-4000U/L
R 2Reagent Concentration (MMOL/L)
O-nitro-β-D-pyranoside 10-20mmol/L
Subordinate list:
Measure reagent and measure the reagent performance relatively with crown ether preparation sodion with cave ether preparation sodion:
Crown ether preparation sodion is measured reagent Cave ether preparation sodion is measured reagent
Two kinds of reagent correlations of linear repeated degree of accuracy Sensitivity Stability Be in the 100-160mmol/L scope in linear batch and can stablize 1 year Y=1.0672X-10.284 under 2-8 ℃ of environment of (n=20) CV (%)<2 ± 5% OD/mmol/L=0.003 Be in the 100-160mmol/L scope in linear batch and can stablize 1 year r=0.9806 under 2-8 ℃ of environment of (n=20) CV (%)<3 ± 5% OD/mmol/L=0.005
Description of drawings
Fig. 1 measures reagent mensuration clinical sample (n=26) correlativity relatively with crown ether preparation sodion mensuration reagent with using cave ether preparation sodion:
The x axle is for measuring the result of clinical sample with the reagent of cave ether preparation;
The y axle is the result who measures clinical sample with the reagent of crown ether preparation.
Beneficial effect
The crown ether that use value of the present invention is more much lower than cave ether, and the mensuration effect reaches similar to cave ether, the characteristics that assay method is easy.
Embodiment
Embodiment:
1. serum sodium ion is measured the reagent composition:
R 1Reagent Concentration (MMOL/L)
TRIS buffer pH8.7 (37 ℃) 500mmol/L
3-mercaptoethanol 5mmol/L
MgSO 4 6mmol/L
LiCl 100mmol/L
Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium 0.5mmol/L
15-is preced with-5 ethers 25mmol/L
β-galactosidase (beta galactosidase) 2000U/L
R 2Reagent Concentration (MMOL/L)
O-nitro-β-D-pyranoside 15mmol/L
Test procedure:
Instrument: full-automatic or semi-automatic biochemical analyzer;
Temperature: 37 ℃; Cuvette 1ml;
Predominant wavelength 405nm; Commplementary wave length: 660nm;
Method two point velocity methods;
Operation;
Blank Standard Sample
Distilled water standard model R 1 40μL 1000μL 40μL 1000μL 40μL 1000μL
Mixing is hatched 5min in 37 ℃, adds then
R 2 400μL 400μL 400μL
Fully mix, hatch 0.5min in 37 ℃, read A 1, read A after the 2min 2, the changes delta A=A of absorbance 2-A 1
Calculate:
Use two standards of height, with the changing value of absorbance the concentration value of corresponding standard items is made typical curve, the concentration of the sample changing value of absorbance is per sample found from typical curve.
Standard items are the standard solution with sodium chloride and potassium chloride preparation, in order to make standard items and clinical sample close, so will add potassium chloride.Compound method is as follows: prepare two base soln: 200mmol/LNaCl earlier, 4mmol/LKCl solution (1#) 1400ml and 4mmol/LKCl solution (2#) 600ml, according to following table two solution are mixed according to certain volume then, just can obtain the height standard items of sodium reagent box.
NaCl concentration mmol/L (theoretical concentration) 120 160
1# liquor capacity (ml) 600 800
2# liquor capacity (ml) 400 200
Because by the concentration of calculating gained is not very accurate, need measure accurate concentration with the electrode method, and then with the quality-control product certificate of inspection of Randox.
2. serum sodium ion is measured the reagent composition:
R 1Reagent Concentration (MMOL/L)
TRIS buffer pH8.7 (37 ℃) 500mmol/L
3-mercaptoethanol 5mmol/L
MgSO 4 6mmol/L
LiCl 50mmol/L
Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium 2.0mmol/L
15-is preced with-5 ethers 20mmol/L
β-galactosidase (beta galactosidase) 4000U/L
R 2Reagent Concentration (MMOL/L)
O-nitro-β-D-pyranoside 10mmol/L
3. serum sodium ion is measured the reagent composition:
R 1Reagent Concentration (MMOL/L)
TRIS buffer pH8.7 (37 ℃) 500mmol/L
3-mercaptoethanol 5mmol/L
MgSO 4 6mmol/L
LiCl 70mmol/L
Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium 5.0mmol/L
15-is preced with-5 ethers 10mmol/L
β-galactosidase (beta galactosidase) 1000U/L
R 2Reagent Concentration (MMOL/L)
O-nitro-β-D-pyranoside 20mmol/L
Above assay method is with embodiment 1.

Claims (4)

1. a serum sodium ion by enzymatic method is measured the composed as follows of reagent: R 1Reagent Concentration (MMOL/L) TRIS buffer pH8.7 (37 ℃) 500mmol/L 3-mercaptoethanol 5mmol/L MgSO 4 6mmol/L LiCl 50-l00mmol/L Ethylene glycol (alpha-amido ethyl) ether tetraacethyl lithium 0.5-5mmol/L 15-is preced with-5 ethers 10-25mmol/L β-galactosidase (beta galactosidase) 1000-4000U/L
R 2Reagent Concentration (MMOL/L) O-nitro-β-D-pyranoside 10-20mmol/L
2. mensuration reagent according to claim 1 is characterized in that crown ether is 15-hat-5 ethers.
3. mensuration reagent as claimed in claim 1 is characterized in that adopting two point velocity methods, and running program is as follows: Blank Standard Sample Distilled water standard model R 1 40μL 1000μL 40μL 1000μL 40μL 1000μL Mixing is hatched 5min in 37 ℃, adds then R 2 400μL 400μL 400μL
Fully mix, hatch 0.5min in 37 ℃, read A 1, read A after the 2min 2, the changes delta A=A of absorbance 2-A 1
Calculate:
Use two standards of height, with the changing value of absorbance the concentration value of corresponding standard items is made typical curve, the concentration of the sample changing value of absorbance is per sample found from typical curve.
4. the purposes of mensuration reagent as claimed in claim 1 is used for measuring the sodion of serum.
CNB2006100284511A 2006-06-30 2006-06-30 Serum sodium ion by enzymatic method is measured reagent and method Expired - Fee Related CN100554939C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100284511A CN100554939C (en) 2006-06-30 2006-06-30 Serum sodium ion by enzymatic method is measured reagent and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100284511A CN100554939C (en) 2006-06-30 2006-06-30 Serum sodium ion by enzymatic method is measured reagent and method

Publications (2)

Publication Number Publication Date
CN1869652A true CN1869652A (en) 2006-11-29
CN100554939C CN100554939C (en) 2009-10-28

Family

ID=37443374

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100284511A Expired - Fee Related CN100554939C (en) 2006-06-30 2006-06-30 Serum sodium ion by enzymatic method is measured reagent and method

Country Status (1)

Country Link
CN (1) CN100554939C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101294927B (en) * 2007-04-27 2013-07-31 株式会社日立高新技术 Ion concentration measuring device and ion concentration measuring element
CN105334211A (en) * 2015-10-20 2016-02-17 北京中生金域诊断技术股份有限公司 Kit simultaneously detecting sodium and creatinine in urine
CN109187522A (en) * 2018-08-31 2019-01-11 山东博科生物产业有限公司 A kind of serum sodium colorimetric determination kit
CN113278676A (en) * 2021-04-23 2021-08-20 深圳市锦瑞生物科技有限公司 Serum sodium detection reagent and gamma-glutamyl transferase detection reagent

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101294927B (en) * 2007-04-27 2013-07-31 株式会社日立高新技术 Ion concentration measuring device and ion concentration measuring element
CN105334211A (en) * 2015-10-20 2016-02-17 北京中生金域诊断技术股份有限公司 Kit simultaneously detecting sodium and creatinine in urine
CN105334211B (en) * 2015-10-20 2018-02-16 北京大学人民医院 It is a kind of while detect the kit of sodium and creatinine in urine
CN109187522A (en) * 2018-08-31 2019-01-11 山东博科生物产业有限公司 A kind of serum sodium colorimetric determination kit
CN113278676A (en) * 2021-04-23 2021-08-20 深圳市锦瑞生物科技有限公司 Serum sodium detection reagent and gamma-glutamyl transferase detection reagent

Also Published As

Publication number Publication date
CN100554939C (en) 2009-10-28

Similar Documents

Publication Publication Date Title
JP4420353B2 (en) General kinase assay
CN104212803A (en) Nucleic acid aptamer sequence and detection method for quantitative and rapid detection of mercury ions
CN111239118A (en) Analysis method for detecting organophosphorus pesticide based on alkaline phosphatase triggered fluorescence and colorimetric dual-reading sensor
CN1869652A (en) Investigating agent and method of serum sodium ion enzyme method
CN104596959A (en) Method for detecting potassium ion concentration based on DNA enzymes
CN1896271A (en) Reagent determination by serum potassium ion enzyme method
CN104048928A (en) Detection kit for direct bilirubin
CN104155289A (en) Solid electrochemical luminescence sensor for detecting mercury ions and preparation method and application of solid electrochemical luminescence sensor for detecting mercury ions
CN107525936B (en) Composition for improving stability of troponin antibody in latex immunoturbidimetry
CN111829999B (en) Application method of perovskite fluorescent microsphere and dopamine system
CN102661943B (en) Method for Measuring Cystine Using Surface Enhanced Raman Spectroscopy
Saeman et al. Analysis of wood sugars
CN1687450A (en) Method measuring N-acetyl-beta-D-amidoglucosaccharase and liquid type stable reagent
Fossati Phosphate determination by enzymatic colorimetric assay
CN111705110A (en) Rapid detection kit for organophosphorus pesticide residues, preparation method and detection method thereof
CN102890078A (en) Method for detecting phenanthroline by using surface-enhanced Raman spectroscopy
CN105842437A (en) Kit for detecting D-3-hydroxybutyric acid and preparation method of kit
CN112345505B (en) Method and application of tetrakis(4-aminobiphenyl)ethylene for detecting hypochlorite
Sun et al. Microdetermination of double-stranded DNA by linear sweep voltammetry with phenosafranine
CN112114016B (en) Electrochemical method for detecting 3-nitropropionic acid
Chen et al. Application of rhodamine B hydrazide as a new fluorogenic indicator in the highly sensitive determination of hydrogen peroxide and glucose based on the catalytic effect of iron (III)-tetrasulfonato-phthalocyanine
CN102998351A (en) Auxiliary reagent for ISE module of biochemical analyzer
CN1219211C (en) Automatic analysis method for COD in sea water
CN1217006C (en) Method for quantitative determination of biochemical substance by enzyme analysis via predicting background
Perez-Bendito et al. Nonenzymatic stopped-flow fluorimetric method for direct determination of uric acid in serum and urine.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091028

Termination date: 20170630

CF01 Termination of patent right due to non-payment of annual fee